Literature DB >> 28216050

Vancomycin induces reactive oxygen species-dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells.

Yuya Sakamoto1, Takahisa Yano2, Yuki Hanada3, Aki Takeshita3, Fumika Inagaki3, Satohiro Masuda4, Naoya Matsunaga5, Satoru Koyanagi5, Shigehiro Ohdo3.   

Abstract

Vancomycin (VCM) is a first-line antibiotic for serious infections caused by methicillin-resistant Staphylococcus aureus. However, nephrotoxicity is one of the most complaint in VCM therapy. We previously reported that VCM induced apoptosis in a porcine proximal tubular epithelial cell line (LLC-PK1), in which mitochondrial complex I may generate superoxide, leading to cell death. In the present study, VCM caused production of mitochondrial reactive oxygen species and peroxidation of the mitochondrial phospholipid cardiolipin that was reversed by administration of the mitochondrial uncoupler carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP). FCCP also significantly suppressed VCM-induced depolarization of the mitochondrial membrane and apoptosis. Moreover, the lipophilic antioxidant vitamin E and a mitochondria-targeted antioxidant, mitoTEMPO, also significantly suppressed VCM-induced depolarization of mitochondrial membrane and apoptosis, whereas vitamin C, n-acetyl cysteine, or glutathione did not provide significant protection. These findings suggest that peroxidation of the mitochondrial membrane cardiolipin mediated the VCM-induced production of intracellular reactive oxygen species and initiation of apoptosis in LLC-PK1 cells. Furthermore, regulation of mitochondrial function using a mitochondria-targeted antioxidant, such as mitoTEMPO, may constitute a potential strategy for mitigation of VCM-induced proximal tubular epithelial cell injury.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antioxidants; Apoptosis; Cardiolipin; Nephrotoxicity; Reactive oxygen species; Vancomycin

Mesh:

Substances:

Year:  2017        PMID: 28216050     DOI: 10.1016/j.ejphar.2017.02.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Rutin Attenuates Vancomycin-Induced Nephrotoxicity by Ameliorating Oxidative Stress, Apoptosis, and Inflammation in Rats.

Authors:  Shaoqi Qu; Cunchun Dai; Fengting Lang; Longfei Hu; Qihe Tang; Haixia Wang; Yanping Zhang; Zhihui Hao
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Vancomycin-Associated Cast Nephropathy: Reality or Fantasy?

Authors:  Michael B Stokes; Jacob S Stevens
Journal:  Kidney360       Date:  2021-12-01

3.  Retracted Article: PVT1 knockdown alleviates vancomycin-induced acute kidney injury by targeting miR-124 via inactivation of NF-κB signaling.

Authors:  Xiaoguang Zhu; Jun Shi; Huicong Li; Fang Chen
Journal:  RSC Adv       Date:  2018-09-12       Impact factor: 4.036

Review 4.  Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.

Authors:  Gwendolyn M Pais; Jiajun Liu; Sanja Zepcan; Sean N Avedissian; Nathaniel J Rhodes; Kevin J Downes; Ganesh S Moorthy; Marc H Scheetz
Journal:  Pharmacotherapy       Date:  2020-05-04       Impact factor: 4.705

Review 5.  Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients?

Authors:  Warren Rose; Michael Fantl; Matthew Geriak; Victor Nizet; George Sakoulas
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

6.  Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older.

Authors:  Yunchao Wang; Ning Dai; Wei Wei; Chunyan Jiang
Journal:  Clin Interv Aging       Date:  2021-06-01       Impact factor: 4.458

7.  ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

Authors:  G Michelle Ducasa; Alla Mitrofanova; Shamroop K Mallela; Xiaochen Liu; Judith Molina; Alexis Sloan; Christopher E Pedigo; Mengyuan Ge; Javier Varona Santos; Yanio Hernandez; Jin-Ju Kim; Cyrille Maugeais; Armando J Mendez; Viji Nair; Matthias Kretzler; George W Burke; Robert G Nelson; Yu Ishimoto; Reiko Inagi; Santanu Banerjee; Shaoyi Liu; Hazel H Szeto; Sandra Merscher; Flavia Fontanesi; Alessia Fornoni
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 19.456

Review 8.  The Nephrotoxicity of Vancomycin.

Authors:  E J Filippone; W K Kraft; J L Farber
Journal:  Clin Pharmacol Ther       Date:  2017-06-05       Impact factor: 6.875

9.  Renoprotective Effects of Melatonin against Vancomycin-Related Acute Kidney Injury in Hospitalized Patients: a Retrospective Cohort Study.

Authors:  Thomas S Hong; Kelsey Briscese; Marshall Yuan; Kiran Deshpande; Lauren M Aleksunes; Luigi Brunetti
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

10.  Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity.

Authors:  Ngoentra Tantranont; Yosu Luque; Mary Hsiao; Claire Haute; Lillian Gaber; Roberto Barrios; Horacio E Adrogue; Aïssata Niasse; Luan D Truong
Journal:  Kidney Int Rep       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.